Prevalence and significance of anaemia in patients receiving long‐course neoadjuvant chemoradiotherapy for rectal carcinoma

Abstract

The prevalence of anaemia in patients undergoing long-course neoadjuvant radiotherapy was 35%. Anaemia during long-course neoadjuvant radiotherapy was associated with significant reductions in tumour downstaging and regression.